FINITE DOSE PERCUTANEOUS DRUG ABSORPTION - THEORY AND ITS APPLICATION TO INVITRO TIMOLOL PERMEATION

被引:30
作者
KUBOTA, K
YAMADA, T
机构
[1] NATL MED CTR, CLIN RES INST, DIV CLIN PHARMACOL, TOKYO, JAPAN
[2] HOSHI UNIV, SCH PHARM, FAC PHARMACEUT SCI, TOKYO, JAPAN
关键词
D O I
10.1002/jps.2600791114
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The finite dose in vitro percutaneous absorption kinetics of timolol, a β‐blocker, was studied. The flux of timolol across excised human abdominal cadaver skin was measured over a period of 72 h following application of a 40‐μm thickness patch containing 5, 10, or 20% (w/v) timolol free base. Amounts of timolol in the patch and skin were also determined at 6, 12, 24, 48, and 72 h after the application of the 20% (w/v) patch. The mean diffusion and partition parameters were estimated to be 0.018 h−1 and 125.9 μm, respectively, using a newly developed theory. Diffusion and partition parameters were estimated using the values for amounts of a drug eventually partitioning into the perfusing water, as well as two newly proposed conceptual parameter values, AUC A v, and AUC A s which are the AUCs of drug amounts in vehicle and skin, respectively. The dose‐dependent skin‐timolol interaction is also discussed. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:1015 / 1019
页数:5
相关论文
共 24 条
[11]  
FRISHMAN WH, 1982, NEW ENGL J MED, V306, P1456
[12]   PERMEATION OF MOUSE SKIN AND SILICONE-RUBBER MEMBRANES BY PHENOLS - RELATIONSHIP TO INVITRO PARTITIONING [J].
JETZER, WE ;
HUQ, AS ;
HO, NFH ;
FLYNN, GL ;
DURAISWAMY, N ;
CONDIE, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (11) :1098-1103
[13]  
KOBUTOA K, 1990, J PHARM SCI, V79, P179
[14]   A DIFFUSION - DIFFUSION-MODEL FOR PERCUTANEOUS DRUG ABSORPTION [J].
KUBOTA, K ;
ISHIZAKI, T .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1986, 14 (04) :409-439
[15]   BETA-BLOCKING-AGENTS - DETERMINATION OF BIOLOGICAL LEVELS USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
LEFEBVRE, MA ;
GIRAULT, J ;
FOURTILLAN, JB .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1981, 4 (03) :483-500
[16]   TRANSDERMAL DRUG DELIVERY - PROBLEMS AND PROMISES [J].
MONKHOUSE, DC ;
HUQ, AS .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (2-3) :183-209
[17]   ANALYSIS OF DRUG PENETRATION THROUGH THE SKIN BY THE 2-LAYER SKIN MODEL [J].
OKAMOTO, H ;
YAMASHITA, F ;
SAITO, K ;
HASHIDA, M .
PHARMACEUTICAL RESEARCH, 1989, 6 (11) :931-937
[18]   STRUCTURE ACTIVITY RELATIONSHIP OF 1-ALKYLAZACYCLOALKANONE OR 1-ALKENYLAZACYCLOALKANONE DERIVATIVES AS PERCUTANEOUS PENETRATION ENHANCERS [J].
OKAMOTO, H ;
HASHIDA, M ;
SEZAKI, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (05) :418-424
[19]   PHARMACOKINETIC CONSIDERATIONS IN THE USE OF NEWER TRANSDERMAL FORMULATIONS [J].
RIDOUT, G ;
SANTUS, GC ;
GUY, RH .
CLINICAL PHARMACOKINETICS, 1988, 15 (02) :114-131